Molbio Diagnostics has made a $30 million investment for acquiring a majority stake in OptraSCAN Inc., a US-based company specializing in digital pathology solutions.
DMD Advocates advised Molbio Diagnostics on this investment deal.
The transaction was led by Ayesha Rai (Partner) along with Pooja Shah (Principal Associate) and Vanshikha Choraria (Associate).
The legal due diligence team consisted of Kajal Tandon (Counsel), Luv Madan (Associate), Parizad Irani (Associate), and Tarush Bhandari (Associate).
Rashi Dhir (Senior Partner & Head of Corporate) and Vihang Virkar (Lead Partner) provided crucial inputs on the transaction.
Roberts Zimmerman PLCC advised on US law related matters, with a team led by Ryan Roberts (Partner).
This acquisition enables Molbio to integrate OptraSCAN’s technology into its portfolio, strengthening its position in the diagnostics market both in India and internationally.
For OptraSCAN, the deal provides capital for growth and expansion while aligning its operations with Molbio’s strategic direction. This partnership enhances the capabilities of both companies, drives innovation, and increases their competitive edge in the healthcare and diagnostics sectors.
If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.